Tianjin Medical University Treats Neonatal Pulmonary Arterial Hypertension with Nitric Oxide

the use of inhaled nitric oxide (iNO) to treat neonatal pulmonary hypertension, recently in Tianjin Medical University SecondHospitalsuccessAfter a week of treatment, the child is in stable condition and will soon be discharged from the hospitalThe application of this technology provides a guarantee for further reduction of perinatal neonatal mortalityThe childmale, full-term caesarean section, birth weight of 3.3 kg, 6 hours after birth due to skin bruising transferred to The Tianjin Medical College neonatal departmentAfter admission to the hospital blood gas analysis and examination indicates severe hypoxemia and acidosis,heartcolor super confirmed that there is serious pulmonary hypertensionAfter routine treatment, the hospital's neonatologist immediately used the latest ventilators and nitric oxide treatment devices introduced from the UKAfter 30 minutes, the child's skin color turned red, review blood gas improved from the previous, 12 hours to check the blood gas normal, gradually reduce the concentration of inhaled nitric oxide, to 38 hours to stop usingAccording to the introduction, the neonatal pulmonary hypertension is more common in full-term or expired children, often exist in the palace hypoxia asphyxiation, serious illness, high mortality rateIn recent years, the clinical efficacy has been improved due to the application of nitric oxide therapy technologyTianjin Medical University will introduce the latest british ventilators and nitric oxide treatment instrument searlyins for clinical use, providing an important guarantee for further reducing the perinatal neonatal mortality rateThis technology is also being developed in other provinces and cities in China